Spero Therapeutics Inc

Lician Pro · $19.99/mo or $149/yr · AAPL vs MSFT

Spero Therapeutics Inc (SPRO) SEC filings

Spero Therapeutics Inc (SPRO) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Latest reported SPRO revenue for 2025-12-31 was $66.8M. Net income was $8.6M. Revenue was up 39.2% from 2024-12-31 to 2025-12-31. SPRO currently screens at market cap $149.5M. The SPRO filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Spero Therapeutics Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.

Earnings & events

All events

Event insights for SPRO — what management said, what changed, and why it matters.

Recent filings

These filings as JSON? API free 100/day

SPRO SEC filings FAQ

What is the latest SPRO SEC filing?

The latest cached Spero Therapeutics Inc (SPRO) filing on this page is 8-K · Aug 28, 2026. Filings: https://lician.com/sec/spro

What is the latest SPRO filing accession number?

The latest cached Spero Therapeutics Inc (SPRO) accession number on this page is 0001193125-26-374788. Filing: https://lician.com/sec/spro/0001193125-26-374788

Which item codes are on the latest SPRO filing?

Cached item codes on the latest Spero Therapeutics Inc (SPRO) 8-K are 1.01, 8.01, 9.01.

How many SPRO SEC filings are listed on this page?

This page lists 3 cached Spero Therapeutics Inc (SPRO) SEC filings. Filings: https://lician.com/sec/spro

What events are listed on the SPRO SEC page?

Cached event headlines on this Spero Therapeutics Inc (SPRO) SEC page: "SPRO earnings". Events: https://lician.com/sec/spro

What are SPRO's latest revenue and net income?

Latest cached Spero Therapeutics Inc (SPRO) revenue for Dec 31, 2025 was $66.8M. Net income was $8.6M. Statements: https://lician.com/financials/spro